Trials / Unknown
UnknownNCT03458156
Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus Nephritis
Clinical Study of Umbilical Cord Mesenchymal Stem Cell Transplantation for Lupus Nephritis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- The First Affiliated Hospital of Dalian Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the safety and efficacy of umbilical cord mesenchymal stem cell transplantation in patients with systemic lupus erythematosus (SLE) and lupus nephritis (LN).
Detailed description
Systemic lupus erythematosus (SLE) is a multisystem autoimmune disease. Lupus nephritis (LN) is one of the most serious complications of SLE. The current clinical treatments of LN mainly include steroids and immunosuppressive drugs, but drug side effects are obvious.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | SLE group | The patients will be assigned to systemic lupus erythematosus (SLE) group, receiving umbilical cord mesenchymal stem cell transplantation. |
| BIOLOGICAL | LN group | The patients will be assigned to lupus nephritis (LN) group, receiving umbilical cord mesenchymal stem cell transplantation. |
| OTHER | the control group | The patients will be assigned to the control group. |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2019-09-01
- Completion
- 2020-01-01
- First posted
- 2018-03-08
- Last updated
- 2018-03-12
Source: ClinicalTrials.gov record NCT03458156. Inclusion in this directory is not an endorsement.